Detalhe da pesquisa
1.
Randomized, double-blind, multicenter phase 2 study comparing the efficacy and safety of oral solithromycin (CEM-101) to those of oral levofloxacin in the treatment of patients with community-acquired bacterial pneumonia.
Antimicrob Agents Chemother
; 57(6): 2526-34, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23507282
2.
Pharmacokinetics and safety of single, multiple, and loading doses of fusidic acid in healthy subjects.
Clin Infect Dis
; 52 Suppl 7: S504-12, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21546627
3.
A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections.
Clin Infect Dis
; 52 Suppl 7: S520-6, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21546629
4.
Pharmacokinetics of solithromycin (CEM-101) after single or multiple oral doses and effects of food on single-dose bioavailability in healthy adult subjects.
Antimicrob Agents Chemother
; 55(5): 1997-2003, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21282444
5.
Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL).
Lancet Infect Dis
; 16(4): 421-30, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26852726